Disease activity in rheumatoid arthritis and the risk of cardiovascular events.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Use of several immunomodulatory agents has been associated with reduced numbers of cardiovascular (CV) events in epidemiologic studies of rheumatoid arthritis (RA). However, it is unknown whether time-averaged disease activity in RA correlates with CV events.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev):

Title: Arthritis & rheumatology (Hoboken, N.J.)

ISSN (Electronic): 2326-5205

ISSN (Print): 2326-5191

Publication date (Electronic): Jun 2015

Volume: 67

Issue: 6

Affiliations

[1 ] Brigham and Women's Hospital, Boston, Massachusetts.

[2 ] University of Massachusetts Medical School, Worcester and the Consortium of Rheumatology Researchers of North America (CORRONA), Southborough, Massachusetts.

[3 ] Albany Medical College and Center for Rheumatology, Albany, New York and CORRONA, Southborough, Massachusetts.

[4 ] University of Alabama at Birmingham.

[5 ] Mount Sinai School of Medicine, New York, New York.

[6 ] University of Maryland School of Medicine, Baltimore.

[7 ] New York University School of Medicine and New York University Hospital for Joint Diseases, New York, New York, and CORRONA, Southborough, Massachusetts.

Article

Mid ID: NIHMS668993

DOI: 10.1002/art.39098

PubMed ID: 25776112

SO-VID: 5cc3d486-d9de-482b-adfe-a233f4e1883c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 86

See all cited by